0001062993-22-012309.txt : 20220512 0001062993-22-012309.hdr.sgml : 20220512 20220512202844 ACCESSION NUMBER: 0001062993-22-012309 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220510 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEN-MAIMON CAROLE CENTRAL INDEX KEY: 0001529611 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 22919783 MAIL ADDRESS: STREET 1: C/O IMPAX LABORATORIES, INC. STREET 2: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Larimar Therapeutics, Inc. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 BUSINESS PHONE: 844-511-9056 MAIL ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN, INC. DATE OF NAME CHANGE: 20100301 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-05-10 0001374690 Larimar Therapeutics, Inc. LRMR 0001529611 BEN-MAIMON CAROLE C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506 BALA CYNWYD PA 19004 1 1 0 0 President and CEO Stock Option (Right to Buy) 2.92 2022-05-10 4 A 0 40000 0 A 2032-05-10 Common Stock 40000 40000 D The option vests 25% on May 10, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting dates. /s/ Jennifer Johansson, Attorney-in-fact 2022-05-10